0000899243-21-010156.txt : 20210305 0000899243-21-010156.hdr.sgml : 20210305 20210305172608 ACCESSION NUMBER: 0000899243-21-010156 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210303 FILED AS OF DATE: 20210305 DATE AS OF CHANGE: 20210305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jacobs Bruce N. CENTRAL INDEX KEY: 0001821074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39460 FILM NUMBER: 21719691 MAIL ADDRESS: STREET 1: C/O KYMERA THERAPEUTICS, INC. STREET 2: 200 ARSENAL YARDS, SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kymera Therapeutics, Inc. CENTRAL INDEX KEY: 0001815442 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812992166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-5314 MAIL ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-03 0 0001815442 Kymera Therapeutics, Inc. KYMR 0001821074 Jacobs Bruce N. C/O KYMERA THERAPEUTICS, INC. 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 0 1 0 0 Chief Financial Officer Common Stock 2021-03-03 4 M 0 20000 2.08 A 20000 D Common Stock 2021-03-03 4 S 0 6881 44.1231 D 13119 D Common Stock 2021-03-03 4 S 0 12019 45.0703 D 1100 D Common Stock 2021-03-03 4 S 0 1100 45.748 D 0 D Stock Option (Right to Buy) 2.08 2021-03-03 4 M 0 20000 0.00 D 2030-08-19 Common Stock 20000 254061 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.56 to $44.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.60 to $45.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.60 to $46.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. /s/ Bruce N. Jacobs 2021-03-05